PBT is registered at Rs 20,070 million at 29.4 per cent

Lupin reported its financial performance for the quarter ending September 30, 2025.

Income Statement Highlights – Q2 FY2026

• Gross profit was at Rs 50,066 million compared to Rs 38,071 million in Q2 FY2025, with a gross margin of 73.3 per cent.
• Personnel cost was 16.2 per cent of sales at Rs 11,056 million compared to Rs 10,075 million in Q2 FY2025.
• Manufacturing and other expenses were 29.0 per cent of sales at Rs 19,796 million compared to Rs 16,670 million in Q2 FY2025.
• PBT at Rs 20,070 million at 29.4 per cent, up 90.3 per cent YoY from Rs 10,549 million in Q2 FY2025.
• Investment in R&D for the quarter was Rs 5,091 Mn (7.5 per cent of sales).

Balance Sheet highlights

• Operating working capital was Rs 77,304 million as on September 30, 2025.
• Capital Expenditure for the quarter was Rs 3,474 million.

• Net Debt as on September 30, 2025, stands at Rs -16,646 million.
• Net Debt Equity as on September 30, 2025, stands at -0.08.

Nilesh Gupta, Managing Director, Lupin said “We are delighted to present one of our strongest performances ever in this second quarter of FY26. We continue to see robust growth in revenues and EBITDA led by strong performance across the board, in the US, emerging markets, other developed markets and in India, supported by higher operational efficiencies and sustained investments. We intend to leverage the performance of H1 to deliver a strong FY26.”